NIAID

The NIH study of the anti-CD14 antibody for the treatment of COVID-19 respiratory disease begins

NIH experts discuss post-acute COVID-19

NIH experts call for accelerated research to simultaneously address HIV and COVID-19 pandemics

NIH and BARDA Statement on FDA Authorization for Emergency Use of Janssen COVID-19 Vaccine

NIH experts discuss the viral variants of SARS-CoV-2

Four potential COVID-19 therapies enter phase 2/3 testing in NIH ACTIV-2 study

The intranasal influenza vaccine stimulates a strong immune response in the phase 1 study

Janssen Investigational COVID-19 Vaccine: Intermediate Analysis of Published Phase 3 Clinical Data

Published a peer-reviewed report on the Modern COVID-19 vaccine

The phase 3 study of the investigative vaccine COVID-19 Novavax opens